Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer
Journal of Ultrasound in Medicine · 2024
DOI: 10.1002/jum.16413 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, 2024. Verfasst von Yan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Children's Hospital of Shanxi Province (Maternal and Child Health Hospital of Shanxi Province), Taiyuan, China. Hauptthemen laut MEDLINE: MicroRNAs, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objectives
To explore clinical value of miRNA‐18a, miRNA‐130a, and miRNA‐92a combined with transvaginal color Doppler ultrasound (TVCDS) in the diagnosis of cervical cancer (CC).
Methods
One hundred patients with pathologically confirmed CC (CC group), 100 patients with cervical epithelial neoplasia (disease group), and 100 patients with benign uterine lesions (control group) were selected. TVCDS was performed, and the levels of serum miRNA‐18a, miRNA‐130a, and miRNA‐92a were detected.
Results
The systolic blood velocity of the cancer group, the disease group, and the control group decreased sequentially, while the resistance index and pulsatility index increased sequentially. The serum miR‐18a, miR‐130a, miR‐92a, and expression levels of the patients' increased sequentially. Multivariate logistic regression analysis showed that age, high‐risk human papillomavirus (HR‐HPV) infection, menopause, blood flow RI, serum miRNA‐18a, miRNA‐92a, and miRNA‐130a were the influencing factors of CC. The receiver operating characteristic curve showed that the sensitivity, specificity, accuracy, and area under curve of transvaginal Doppler ultrasound in the diagnosis of CC were 86.43%, 88.01%, 84.32%, and 0.913; serum miR‐18a were, respectively, 76.56, 81.30, 80.36, and 0.839; serum miR‐130a were 77.88%, 76.97%, 78.32%, and 0.0.864; serum miR‐92a were 71.04%, 80.39%, 80.74%, and 0.894; 90.33%, 95.14%, 91.25%, and 0.947, the area under curve of the combined detection of the 3 was greater than that of the single detection.
Conclusions
Serum miRNA combined with TVCDS has the advantages of it being noninvasive, and having high sensitivity and high specificity in the diagnosis of CC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Children's Hospital of Shanxi Province (Maternal and Child Health Hospital of Shanxi Province), Taiyuan, China.
- Department of one inpatient ward of Breast Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical Univers…
- Department of Ultrasound, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Zitieren
APA
Wang, Y., Yang, J., & Wang, Y. (2024). Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16413
Vancouver
Wang Y, Yang J, Wang Y. Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer. Journal of Ultrasound in Medicine. 2024. doi:10.1002/jum.16413
BibTeX
@article{Wang2024,
author = {Wang, Yan and Yang, Jun and Wang, Yin},
title = {Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer},
journal = {Journal of Ultrasound in Medicine},
year = {2024},
doi = {10.1002/jum.16413}
}
EUVIMED